Caremark

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - February 11, 2026 (FTC - Federal Trade Commission)

Public Technologies 12 Feb 2026

) February 11, 2026. File. (147.55 KB). File. (1.18 MB).

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) - (Last Updated: February 11, 2026 - Case Status: Pending) (FTC - Federal Trade Commission)

Public Technologies 11 Feb 2026

In the Matter of Caremark Rx, LLC; Zinc Health Services LLC; Express Scripts, Inc.; Evernorth Health, Inc.; Medco Health Services, Inc.; Ascent Health Services LLC; OptumRx, Inc.; OptumRx Holdings LLC; and Emisar Pharma Services LLC, Respondents.

Edit

Celltrion’s Stoboclo Listed on CVS Caremark Formulary, One of the Three Largest PBMs in the U.S.... Successive listings with major PBMs accelerate early market penetration (Celltrion Inc)

Public Technologies 06 Feb 2026

With this listing, Celltrion has successfully completed preferred formulary placement on CVS Caremark for both biosimilars referencing Prolia and XGEVA ... The decision reflects CVS Caremark's assessment ...

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - February 4, 2026 (FTC - Federal Trade Commission)

Public Technologies 05 Feb 2026

) February 4, 2026. File. (1.6 MB). File. (7.54 MB). File. (2.61 MB).

Edit

Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices

New York Times 04 Feb 2026

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits ... .

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 30, 2026 (FTC - Federal Trade Commission)

Public Technologies 02 Feb 2026

) January 30, 2026. File. (114.99 KB). Attachments Original document Permalink.

Edit

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs. (FTC - Federal Trade Commission)

Public Technologies 02 Feb 2026

In the Matter of Caremark Rx, LLC; Zinc Health Services LLC; Express Scripts, Inc.; Evernorth Health, Inc.; Medco Health Services, Inc.; Ascent Health Services LLC; OptumRx, Inc.; OptumRx Holdings LLC; and Emisar Pharma Services LLC, Respondents.

Edit

Finding Potential Caremark and Duty of Loyalty Violations, Chancery Compounds Uncertainty on Its Approach to Workplace Sexual Misconduct Cases—eXp World (Fried, Frank, Harris, Shriver & Jacobson LLP)

Public Technologies 29 Jan 2026

The court concluded, however, that the Facebook post in 2020 that detailed sexual misconduct at eXp and went viral constituted a "red flag" for the board for Caremark purposes.

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 21, 2026 (FTC - Federal Trade Commission)

Public Technologies 22 Jan 2026

) January 21, 2026. File. (171.61 KB). Attachments Original document Permalink.

Edit

House panel finds CVS Caremark may have broken antitrust laws

The Hill 21 Jan 2026

... possible anticompetitive practices by the company’s PBM, CVS Caremark, ....

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 20, 2026 (FTC - Federal Trade Commission)

Public Technologies 21 Jan 2026

) January 20, 2026. File. (225.63 KB). File. (674.29 KB). File.

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 15, 2026 (FTC - Federal Trade Commission)

Public Technologies 16 Jan 2026

) January 15, 2026. File. (1.37 MB). Attachments Original document Permalink.

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 12, 2026 (FTC - Federal Trade Commission)

Public Technologies 13 Jan 2026

) January 12, 2026. File. (862.06 KB). File. (933.79 KB).

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 9, 2026 (FTC - Federal Trade Commission)

Public Technologies 12 Jan 2026

) January 9, 2026. File. (1.3 MB). File. (3 MB). File ... Disclaimer.

Edit

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 8, 2026 (FTC - Federal Trade Commission)

Public Technologies 09 Jan 2026

) January 8, 2026. File. (953.47 KB). File. (1 MB) ... Disclaimer.

Podcasts:

Latest News for: caremark

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - February 11, 2026 (FTC - Federal Trade Commission)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) - (Last Updated: February 11, 2026 - Case Status: Pending) (FTC - Federal Trade Commission)

Celltrion’s Stoboclo Listed on CVS Caremark Formulary, One of the Three Largest PBMs in the U.S.... Successive listings with major PBMs accelerate early market penetration (Celltrion Inc)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - February 4, 2026 (FTC - Federal Trade Commission)

Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 30, 2026 (FTC - Federal Trade Commission)

Finding Potential Caremark and Duty of Loyalty Violations, Chancery Compounds Uncertainty on Its Approach to Workplace Sexual Misconduct Cases—eXp World (Fried, Frank, Harris, Shriver & Jacobson LLP)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 21, 2026 (FTC - Federal Trade Commission)

House panel finds CVS Caremark may have broken antitrust laws

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 20, 2026 (FTC - Federal Trade Commission)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 15, 2026 (FTC - Federal Trade Commission)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 12, 2026 (FTC - Federal Trade Commission)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 9, 2026 (FTC - Federal Trade Commission)

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) (timeline item) - January 8, 2026 (FTC - Federal Trade Commission)

Article Search

EXPLORE WN.com